Mesenchymal Stromal Cells(Banc de Sang i Teixits)(Mesenchymal Stromal Cells(Banc de Sang i Teixits))

概要

基本信息

药物类型

间充质干细胞疗法

别名

XCEL-MT-OSTEO-ALPHA

靶点-

作用方式-

作用机制

干细胞替代物

治疗领域

其他疾病

在研适应症-

非在研适应症

萎缩性不愈合骨折假关节

原研机构

Banc de Sang I Teixits

在研机构-

非在研机构

Banc de Sang I Teixits

权益机构-

最高研发阶段无进展临床1/2期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

1

项与 Mesenchymal Stromal Cells(Banc de Sang i Teixits) 相关的临床试验

NCT02230514

/ Completed临床1/2期IIT

A Phase IIa, Single Center, Prospective, Randomized, Parallel, Two-arms, Single-dose, Open-label With Blinded Assessor Pilot Clinical Trial to Assess ex Vivo Expanded Adult Autologous Mesenchymal Stromal Cells Fixed in Allogeneic Bone Tissue (XCEL-MT-OSTEO-ALPHA) in Non Hypertrophic Pseudoarthrosis of Long Bones

The present study evaluates the effect of XCEL-MT-OSTEO-ALPHA in non-union fractures (pseudoarthrosis) of long bones in comparison to the standard treatment of autologous iliac crest.
XCEL-MT-OSTEO-ALPHA is a tissue engineering product composed by "ex-vivo" expanded autologous mesenchymal stromal cells fixed in allogenic bone tissue, produced by Xcelia (Blood and Tissue Bank of Catalonia).
The working hypothesis proposes that the tissue engineering is a valid and useful technique to achieve bone regeneration up to consolidation of non-union fractures.

开始日期2014-11-20

申办/合作机构

Banc de Sang I Teixits

100 项与 Mesenchymal Stromal Cells(Banc de Sang i Teixits) 相关的临床结果

登录后查看更多信息

100 项与 Mesenchymal Stromal Cells(Banc de Sang i Teixits) 相关的转化医学

登录后查看更多信息

100 项与 Mesenchymal Stromal Cells(Banc de Sang i Teixits) 相关的专利（医药）

登录后查看更多信息

100 项与 Mesenchymal Stromal Cells(Banc de Sang i Teixits) 相关的药物交易

登录后查看更多信息